Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
REVIVO BioSystems develops advanced organ-on-a-chip platforms using proprietary "explants-on-chip" and "skin-on-chip" technologies to create realistic human tissue models. These are used for high-throughput in vitro testing of chemical, cosmetic, and pharmaceutical products—enabling permeability, safety, efficacy, mode-of-action studies without animal experimentation. The company has won innovation awards for its ethical approach to preclinical research. It does not develop therapeutics but supports R&D pipelines across the life sciences sector by providing more predictive human-relevant data.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on REVIVO BioSystems.